- Home
- SOBR vs MBIO Comparison
SOBR vs MBIO Comparison
Compare SOBR & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOBR
- MBIO
- Stock Information
- Founded
- SOBR 2004
- MBIO 2015
- Country
- SOBR United States
- MBIO United States
- Employees
- SOBR N/A
- MBIO N/A
- Industry
- SOBR Newspapers/Magazines
- MBIO Biotechnology: Pharmaceutical Preparations
- Sector
- SOBR Consumer Discretionary
- MBIO Health Care
- Exchange
- SOBR Nasdaq
- MBIO Nasdaq
- Market Cap
- SOBR 5.2M
- MBIO 4.7M
- IPO Year
- SOBR N/A
- MBIO N/A
- Fundamental
- Price
- SOBR $3.20
- MBIO $1.43
- Analyst Decision
- SOBR
- MBIO
- Analyst Count
- SOBR 0
- MBIO 0
- Target Price
- SOBR N/A
- MBIO N/A
- AVG Volume (30 Days)
- SOBR 20.2K
- MBIO 147.7K
- Earning Date
- SOBR 08-07-2025
- MBIO 11-07-2025
- Dividend Yield
- SOBR N/A
- MBIO N/A
- EPS Growth
- SOBR N/A
- MBIO N/A
- EPS
- SOBR N/A
- MBIO N/A
- Revenue
- SOBR $301,400.00
- MBIO N/A
- Revenue This Year
- SOBR N/A
- MBIO N/A
- Revenue Next Year
- SOBR N/A
- MBIO N/A
- P/E Ratio
- SOBR N/A
- MBIO N/A
- Revenue Growth
- SOBR 73.21
- MBIO N/A
- 52 Week Low
- SOBR $2.41
- MBIO $0.89
- 52 Week High
- SOBR $193.50
- MBIO $21.95
- Technical
- Relative Strength Index (RSI)
- SOBR 40.16
- MBIO 39.31
- Support Level
- SOBR $2.98
- MBIO $1.51
- Resistance Level
- SOBR $3.43
- MBIO $1.59
- Average True Range (ATR)
- SOBR 0.22
- MBIO 0.09
- MACD
- SOBR -0.01
- MBIO -0.01
- Stochastic Oscillator
- SOBR 36.07
- MBIO 2.89
About SOBR SOBR Safe Inc.
Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending ea4 software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.
About MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.